Designer Babies: Human cloning is a long way off, but bioengineered kids are already here.
By Shannon Brownlee,
The Washington Monthly
| 02. 28. 2002
In the mid-1990s, embryologist Jacques Cohen pioneered a promising
new technique for helping infertile women have children. His
technique, known as cytoplasmic transfer, was intended to "rescue"
the eggs of infertile women who had undergone repeated, unsuccessful
attempts at in vitro fertilization, or IVF. It involved injecting
the cytoplasm found inside the eggs of a fertile donor, into
the patient's eggs.
When the first baby conceived through cytoplasmic transfer was
born in 1997, the press instantly hailed Cohen's technique as
yet another technological miracle. But four years later, the
real story has proven somewhat more complicated. Last year,
Cohen and his colleagues at the Institute for Reproductive Medicine
and Science of St. Barnabas, a New Jersey fertility clinic,
set off alarm bells among bioethicists with the publication
of a paper detailing the genetic condition of two the 17 cytoplasmic-transfer
babies born through the clinic to date. The embryologists reported
that they had endowed the children with extra bits of a special
type of genetic material, known as mitochondrial DNA, or mtDNA,
which came with the cytoplasm transferred from the donor...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...